First Morning Void Profile

Description

Once a patient is on track with a therapeutic plan, the First Morning Void is a good way to monitor therapies that are not focused around the HPA-Axis (which can only be monitored in a 24-hour profile). The single-sample collection covers an 8-12-hour window of hormone assessment, which has better reproducibility and accuracy over serum or saliva testing and includes the Testosterone, DHEA, Estrogen and Progesterone metabolites, as well as the anabolic and catabolic pathway markers.